Vita Coco Company, INC Form 4 insider transactions

NASDAQ
Vita Coco's Chief Operating Officer, Jonathan Burth, exercised stock options and sold a portion of his holdings under a pre-arranged 10b5-1 trading plan.
NASDAQ
Charles van Es, Chief Sales Officer of Vita Coco, reported a gift of 2,000 common shares and detailed his holdings of non-qualified stock options.
NASDAQ
Vita Coco's CEO, Martin Roper, executed multiple sales of company stock under a pre-arranged 10b5-1 trading plan, both directly and through family trusts.
NASDAQ
Vita Coco's Chief Operating Officer, Jonathan Burth, engaged in multiple stock transactions, including sales and a charitable donation, while also holding various non-qualified stock options.
NASDAQ
Vita Coco's CEO, Martin Roper, executed multiple sales of company stock under a pre-arranged 10b5-1 trading plan, both directly and through family trusts.
NASDAQ
Jane Prior, Chief Marketing Officer of Vita Coco, exercised stock options and sold a portion of her shares on December 11, 2024, according to a recent SEC filing.
NASDAQ
Vita Coco's Chief Financial Officer, Corey Baker, sold 2,000 shares of common stock at $37.28 per share on December 11, 2024, while retaining significant holdings including vested and unvested stock options.
NASDAQ
Vita Coco's CEO, Martin Roper, and related family trusts sold shares of common stock under a pre-arranged 10b5-1 trading plan.
NASDAQ
Vita Coco's CEO, Martin Roper, sold a total of 40,000 shares of common stock through a pre-arranged 10b5-1 trading plan over two days, with prices ranging from $35.57 to $36.88.
NASDAQ
Verlinvest Beverages SA acquired 629 shares of Vita Coco Company common stock through the vesting of restricted stock units held by a nominee.
NASDAQ
Director John Zupo of Vita Coco Company, Inc. acquired 629 shares of common stock and holds options for 38,675 shares.
NASDAQ
Director Kenneth Sadowsky of Vita Coco Company, Inc. acquired 629 shares of common stock and holds options for 27,300 shares.
NASDAQ
Director Jane Morreau of Vita Coco Company, Inc. acquired 629 shares of common stock and holds options for 45,500 shares.
NASDAQ
Director Eric Melloul reported the acquisition of 629 restricted stock units (RSUs) and indirect beneficial ownership of over 10 million shares of Vita Coco Company, Inc.
NASDAQ
Director Ira Liran acquired 629 shares of Vita Coco stock through a restricted stock unit (RSU) grant, while also holding a significant number of shares indirectly through a family trust.
NASDAQ
Director John Leahy of Vita Coco Company, Inc. acquired 629 shares of common stock and holds options for 27,300 shares.
NASDAQ
Director Aishetu Fatima Dozie of Vita Coco Company, Inc. acquired 629 shares of common stock through a restricted stock unit (RSU) grant.
NASDAQ
Charles van Es, Chief Sales Officer of Vita Coco, sold 4,978 shares of common stock to cover taxes and fees related to the vesting of restricted stock units.
NASDAQ
Vita Coco's CEO, Martin Roper, executed multiple sales of common stock under a pre-arranged 10b5-1 trading plan, both directly and through family trusts.
NASDAQ
Jane Prior, Chief Marketing Officer of Vita Coco, sold shares to cover taxes and fees related to vesting stock and also exercised and sold stock options under a 10b5-1 trading plan.
NASDAQ
Vita Coco's Chief Operating Officer, Jonathan Burth, sold 1,432 shares of common stock to cover taxes and fees related to the vesting of restricted stock units.
NASDAQ
Vita Coco's Chief Operating Officer, Jonathan Burth, sold 10,000 shares of common stock at an average price of $35.689, according to a recent SEC filing.
NASDAQ
Vita Coco's CEO, Martin Roper, executed multiple sales of company stock under a pre-arranged 10b5-1 trading plan, while also holding significant stock options.
NASDAQ
Vita Coco's CEO, Martin Roper, executed multiple sales of company stock under a pre-arranged 10b5-1 trading plan, both directly and through family trusts.
NASDAQ
Vita Coco's CEO, Martin Roper, executed multiple sales of company stock under a pre-arranged 10b5-1 trading plan.
NASDAQ
Jane Prior, Chief Marketing Officer of Vita Coco, exercised stock options and sold shares on November 21, 2024, according to a recent SEC filing.
NASDAQ
Vita Coco's CEO, Martin Roper, sold a total of 40,000 shares of common stock through a pre-arranged 10b5-1 trading plan, with some shares sold directly and others through family trusts.
NASDAQ
Vita Coco's CEO, Martin Roper, sold a total of 40,000 shares of common stock through a pre-arranged 10b5-1 trading plan, with transactions occurring on November 18th and 19th, 2024.
NASDAQ
Vita Coco's Chief Financial Officer, Corey Baker, sold 5,172 shares of common stock at an average price of $34.027, according to a recent SEC filing.
NASDAQ
Vita Coco's CEO, Martin Roper, executed multiple sales of company stock under a pre-arranged 10b5-1 trading plan, both directly and through family trusts.